Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Evaluation of mutation rate in plasmid and virus

ABSTRACT: Evaluation of mutation rate in plasmid and virus

PROVIDER: PRJNA611838 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11285338_1.fastq.gz	Fastqsanger.gz
	SRR11285338_2.fastq.gz	Fastqsanger.gz
	SRR11285339_1.fastq.gz	Fastqsanger.gz
	SRR11285339_2.fastq.gz	Fastqsanger.gz
	SRR11285340_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 50

Similar Datasets

Evaluation of mutation rate in plasmid and virus

Project description:We report the mutation profile of measles F gene by saturating mutagenesis.

2020-12-09 | GSE146767 | GEO

C_rip mutation rate

Project description:Direct estimation of the spontaneous mutation rate by short-term mutation accumulation lines in Chironomus riparius

| PRJEB18039 | ENA

Heliconius melpomene mutation rate

Project description:Estimation of the spontaneous mutation rate in Heliconius melpomene

| PRJEB7581 | ENA

Quantification of basal RNA mutation rate in the repRNA-v4 EGFP region

Project description:REPLACE was engineered from an orthogonal alphaviral RNA replication system. It generates a large, continuously diversified library of replicative RNAs through a replicase-limited mode of replication and inducible mutagenesis. We analyzed the mutation frequency at Day0 (IVT RNA), Day1, Day3, Day7, Day14, Day21 and DNA plasmid to estimate the RNA mutation rate. This data was used to guide the construction of RNA mutant libraries.

2024-09-30 | GSE271880 | GEO

Mutation rate and recent of evolution of Hydra

Project description:Mutation rate and recent of evolution of Hydra

| PRJEB50344 | ENA

Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus

Project description:A previous study showed that a plasmid expressing IFNa (pIFNa) strongly enhanced protection and antibody production of a DNA vaccine against infectious salmon anemia virus (ISAV) in Atlantic salmon. The vaccine consisted of a plasmid (pHE) expressing the virus hemagglutinin-esterase as an antigen. To increase the understanding of the adjuvant effect of pIFNa, here compared transcriptome responses in salmon muscle at the injection site at week 1 and 2 after injection of pIFNa, pHE, plasmid control (pcDNA3.3) and PBS,respectively. A major was that both the control plasmid pcDNA3.3 and pHE caused responses similar to pIFNa, but at lower magnitude. Plasmid DNA may thus by itself have adjuvant activity as observed in mammalian models. Notably, pHE had a lower effect on many immune genes including ISGs and chemokines than pcDNA3.3, which suggested an inhibitory effect of the viral protein

2017-10-25 | GSE106111 | GEO

Sun2018 - Instantaneous mutation rate in cancer initiation and progression

Project description:Background Cancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to explore the mechanisms of cancer initiation and progression. The investigation for these problems is very important for the diagnosis of cancer diseases and development of treatment schemes. Results To accurately describe the process of cancer initiation, we propose a new concept of gene initial mutation rate based on our recently designed mathematical model using the non-constant mutation rate. Unlike the widely-used average gene mutation rate that depends on the number of mutations, the gene initial mutation rate can be used to describe the initiation process of a single patient. In addition, we propose the instantaneous tumour doubling time that is a continuous function of time based on the non-constant mutation rate. Our proposed concepts are supported by the clinic data of seven patients with advanced pancreatic cancer. The regression results suggest that, compared with the average mutation rate, the estimated initial mutation rate has a larger value of correlation coefficient with the patient survival time. We also provide the estimated tumour size of these seven patients over time. Conclusions The proposed concepts can be used to describe the cancer initiation and progression for different patients more accurately. Since a quantitative understanding of cancer progression is important for clinical treatment, our proposed model and calculated results may provide insights into the development of treatment schemes and also have other clinic implications.

2024-09-02 | BIOMD0000000915 | BioModels

Evaluation of drug escape mutant in Sendai virus

Project description:Evaluation of drug escape mutant in Sendai virus

| PRJNA589542 | ENA

DNA methylation and mutation rate in fungal pathogen

Project description:Recent loss of the Dim2 cytosine DNA methyltransferase impacts mutation rate and evolution in a fungal plant pathogen

| PRJEB37128 | ENA

Quantification of basal RNA mutation rate in the repRNA-v4 EGFP region

Project description:Quantification of basal RNA mutation rate in the repRNA-v4 EGFP region

| PRJNA1133799 | ENA